TMSOTf-catalyzed synthesis of trisubstituted imidazoles using hexamethyldisilazane as a nitrogen source under neat and microwave irradiation conditions

In the process of drug discovery and development, an efficient and expedient synthetic method for imidazole-based small molecules from commercially available and cheap starting materials has great significance. Herein, we developed a TMSOTf-catalyzed synthesis of trisubstituted imidazoles through the reaction of 1,2-diketones and aldehydes using hexamethyldisilazane as a nitrogen source under microwave heating and solvent-free conditions. The chemical structures of representative trisubstituted imidazoles were confirmed using X-ray single-crystal diffraction analysis. This synthetic method has several advantages including the involvement of mild Lewis acid, being metal- and additive-free, wide substrate scope with good to excellent yields and short reaction time. Furthermore, we demonstrate the application of the methodology in the synthesis of biologically active imidazole-based drugs.

Trisubstituted imidazoles are synthesized efficiently from the readily available 1,2-diketones and aldehydes using hexamethyldisilazane as a new and stable nitrogen source under TMSOTf-catalysis system, microwave heating and solvent-free conditions.

A remarkable phosphorescent sensor for acid–base vapours based on an AIPE-active Ir(iii) complex

A novel AIPE-active neutral mononuclear Schiff base ligand Ir(iii) complex has been synthesized for rapid and reversible phosphorescent sensing of acid–base vapours.

Aggregation-Induced Electrochemiluminescence from a Cyclometalated Iridium(III) Complex

Aggregation-induced emission has been extensively found in organic compounds and metal complexes. In contrast, aggregation-induced electrochemiluminescence (AI-ECL) is rarely observed. Here, we employ two tridentate ligands [2,2':6',2″-terpyridine (tpy) and 1,3-bis(1 H-benzimidazol-2-yl)benzene (bbbiH₃)] to construct a cyclometalated iridium(III) complex, [Ir(tpy)(bbbi)] (1), showing strong AI-ECL. Its crystal structure indicates that neighboring [Ir(tpy)(bbbi)] molecules are connected through both π-π-stacking interactions and hydrogen bonds. These supramolecular interactions can facilitate the self-assembly of complex 1 into nanoparticles in an aqueous solution. The efficient restriction of molecular vibration in these nanoparticles leads to strong AI-ECL emission of complex 1. In a dimethyl sulfoxide-water (H₂O) mixture with a gradual increase in the H₂O fraction from 20% to 98%, complex 1 showed a ∼39-fold increase in the electrochemiluminescence (ECL) intensity, which was ∼4.04 times as high as that of [Ru(bpy)₃]²⁺ under the same experimental conditions. Moreover, the binding of bovine serum albumin to the nanoparticles of complex 1 can improve the ECL emission of this complex, facilitating the understanding of the mechanism of AI-ECL for future applications.

Cyclometalated Ir(iii) complexes [Ir(tpy)(bbibH2)Cl][PF6] and [Ir(tpy)(bmbib)Cl][PF6]: intramolecular π⋯π interactions leading to facile synthesis and enhanced luminescence

Complexes [Ir(tpy)(bbibH₂)Cl][PF₆] (1·PF6) and [Ir(tpy)(bmbib)Cl][PF₆] (2·PF6) show facile synthesis and enhanced luminescence due to intramolecular π⋯π interactions.

Alkyl chain-modified cyclometalated iridium complexes as tunable anticancer and imaging agents

Imidazole-based cyclometalated iridium complexes [1]⁺–[5]⁺ have been developed displaying alkyl chain length dependent anticancer activity and imaging property.

Cyclometalated Ir(iii) complexes incorporating a photoactive anthracene-based ligand: syntheses, crystal structures and luminescence switching by light irradiation

Compound aip and its Ir(iii) complexes [Ir(dfppy)₂(aip)](PF₆) (1) and [Ir(ppy)₂(aip)](PF₆) (2) show light-irradiation-induced luminescence switching behaviors.